Gyomor- és nyelőcsőrák: vizsgálatok itt: Japán
55 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Study of [68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors
- Where
- Kyoto
- Életkor
- 18 év and over
- People
- 66 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07801508 - 2. fázisTaking peopleA Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
- Where
- Chūōku, Kashiwa, Kōtoku, Nagaizumi-chō, Shinden, Yokohama
- Életkor
- 18 év and over
- People
- 146 worldwide
- Run by
- Toray Industries, Inc
See details and how to joinNCT06038578 - 1/2. fázisTaking peopleA Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Where
- Chūōku, Kashiwa
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07115043 - 1/2. fázisTaking peopleA Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)
- Where
- Chuo-ku, Kashiwa, Kitaadachi-gun, Nagaizumi-cho,Sunto-gun, Nagoya
- Életkor
- 18 év and over
- People
- 230 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05319730 · EU 2023-505189-26-00 - 2. fázisTaking peopleAZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
- Where
- Chūōku, Kashiwa, Kitaadachi-gun, Kōtoku, Nagoya, Osakasayama-shi
- Életkor
- 18 év and over
- People
- 226 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00 - 1/2. fázisTaking peopleStudy of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
- Where
- Chūōku, Kashiwa, Kōtoku
- Életkor
- 18 év and over
- People
- 392 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06005493 · EU 2023-504139-42-00 - 2. fázisTaking peopleStudy of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Where
- Chūōku, Kashiwa, Kōtoku, Nagoya, Shinagawa-ku, Suita-shi
- Életkor
- 18 év to 130 év
- People
- 454 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00 - 1. fázisTaking peopleEvaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Where
- Chūōku
- Életkor
- 18 év and over
- People
- 540 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT05983432 - 1/2. fázisTaking peopleA Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
- Where
- Bunkyoku, Kōtoku, Sakai
- Életkor
- 18 év and over
- People
- 630 worldwide
- Run by
- BeOne Medicines
See details and how to joinNCT06427941 · EU 2025-524136-19-00 - 1/2. fázisTaking peopleGAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites
- Where
- Fukuoka
- Életkor
- 20 év and over
- People
- 176
- Run by
- Kyushu University
See details and how to joinNCT05438459 - 1. fázisTaking peopleA Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- Where
- Chuo Ku, Kashiwa, Koto-ku, Nagoya, Sakai, Suita, Yokohama
- Életkor
- 18 év and over
- People
- 398 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT05365581 · EU 2023-504514-29-00 - 2. fázisNot yet taking people in JapánStudy of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Where
- Kashiwa, Yokohama
- Életkor
- 18 év to 64 év
- People
- 257 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06535607 · EU 2025-523947-36-00 - No phaseNot yet taking people in JapánExercise Training After Upper Gastrointestinal Cancer Surgery
- Where
- Hirakata
- Életkor
- 18 év and over
- People
- 171
- Run by
- Kansai Medical University
See details and how to joinNCT07561840 - 1/2. fázisTaking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 1109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - 3. fázisTaking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Bunkyō City, Chūōku, Gifu, Hiroshima, Kashiwa-shi, Kitakyushu, Kochi, Kōtoku, Matsuyama, Nagoya, Natori-shi, Niigata, Osaka, Osakasayama-Shi, Sapporo, Suita-shi, Yokohama
- Életkor
- 18 év and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - 1. fázisTaking peopleAB122 Platform Study
- Where
- Aichi, Chiba, Ehime, Hokkaido, Kanagawa, Osaka, Shizuoka, Tokyo, Wakayama
- Életkor
- 18 év and over
- People
- 917
- Run by
- Taiho Pharmaceutical Co., Ltd.
See details and how to joinNCT04999761 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Kashiwa, Nagaizumi-chō
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - 1. fázisTaking peopleA Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Where
- Kashiwa
- Életkor
- 18 év and over
- People
- 914 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT06131840 · EU 2023-505858-18-00 - No phaseTaking peoplePredicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
- Where
- Chūō, Nagoya
- Életkor
- 20 év and over
- People
- 150
- Run by
- City of Hope Medical Center
See details and how to joinNCT06476067 - No phaseTaking peoplePredicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
- Where
- Chūō
- Életkor
- 20 év and over
- People
- 150
- Run by
- City of Hope Medical Center
See details and how to joinNCT06490003 - No phaseTaking peoplePredicting Peripheral Neuropathy of Paclitaxel for Gastric Cancer
- Where
- Kurashiki
- Életkor
- 20 év and over
- People
- 150
- Run by
- City of Hope Medical Center
See details and how to joinNCT06490159 - 1. fázisTaking peopleStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
- Where
- Chuo-ku, Hirakata-shi, Kashiwa-shi, Kobe, Nagoya, Sunto-gun, Wakayama
- Életkor
- 18 év and over
- People
- 694 worldwide
- Run by
- AbbVie
See details and how to joinNCT05005403 - 2. fázisTaking peopleNovel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Chūōku, Kashiwa, Sunto-gun
- Életkor
- 18 év and over
- People
- 163 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05702229 · EU 2024-510977-27-00 - 2. fázisTaking peopleGivastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
- Where
- Kashiwa, Tokyo
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- I-Mab Biopharma US Limited
See details and how to joinNCT07432295 - 3. fázisTaking peopleA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Where
- Akashi-shi, Chuo Ku, Chuo-ku Osaka-shi, Gifu, Hamamatsu, Hiroshima, Izumi-shi, Kanazawa, Kasama-shi, Kōtoku, Maebashi, Osaka, Osaki-Shi, Saitama, Sapporo, Shizuoka, Suita, Takamatsu, Takatsuki-shi, Toyonaka-shi, Utsunomiya, Wakayama, Yamagata
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06532006 · EU 2024-516633-12-00